SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-291716
Filing Date
2023-12-08
Accepted
2023-12-08 16:31:30
Documents
5
Effectiveness Date
2023-12-08

Document Format Files

Seq Description Document Type Size
1 S-8 d636191ds8.htm S-8 65176
2 EX-5.1 d636191dex51.htm EX-5.1 8361
3 EX-23.1 d636191dex231.htm EX-23.1 1523
4 EX-FILING FEES d636191dexfilingfees.htm EX-FILING FEES 51447
5 GRAPHIC g636191dsp8.jpg GRAPHIC 4634
  Complete submission text file 0001193125-23-291716.txt   134290
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275962 | Film No.: 231475854
SIC: 2834 Pharmaceutical Preparations